Ureteric Perfusion During Prolonged Hemodynamic Instability

Abstract

Ureteric perfusion is highly vulnerable during prolonged hemodynamic instability, particularly in patients with septic shock, hemorrhage, cardiogenic shock, major surgery, or sustained exposure to vasopressor therapy. Although the kidneys receive substantial cardiac output, ureteral blood flow is comparatively limited and depends on a delicate longitudinal vascular network derived from the renal, gonadal, aortic, common iliac, and pelvic arterial systems. Hypoperfusion may impair ureteral peristalsis, compromise tissue oxygenation, delay healing, and increase the risk of ischemic stricture, urinary leakage, necrosis, and infection. Clinical recognition is difficult because ureteric ischemia is uncommon, frequently masked by acute kidney injury, and may become apparent only after stabilization or urinary diversion. This review summarizes the epidemiology, mechanisms, risk factors, clinical manifestations, diagnostic approach, management principles, emerging technologies, and guideline-informed strategies relevant to ureteric perfusion during prolonged circulatory compromise. Early restoration of systemic perfusion, avoidance of unnecessary vascular disruption, careful ureteral handling, and postoperative surveillance are central to prevention and treatment. Multidisciplinary coordination between critical care, urology, radiology, vascular surgery, and transplant teams is essential in high-risk patients.

Introduction

Ureteric perfusion is an important but relatively underrecognized determinant of urinary tract integrity in critically ill and surgically complex patients. The ureter is not merely a passive conduit; it requires adequate oxygen delivery to sustain smooth-muscle activity, mucosal viability, coordinated peristalsis, and repair after instrumentation or surgical mobilization. During prolonged hemodynamic instability, the body preferentially redistributes blood flow toward the heart and brain. Renal and pelvic tissues may consequently experience reduced oxygen delivery, particularly when hypotension is combined with vasoconstriction, endothelial dysfunction, anemia, hypoxemia, or local vascular interruption.

The clinical problem is relevant in intensive care, emergency surgery, complex pelvic surgery, transplantation, aortic intervention, and urological reconstruction. Ureteric injury is more commonly attributed to direct transection, ligation, thermal damage, or obstruction, yet ischemic injury may coexist with or amplify each of these mechanisms. A ureter that appears intact intraoperatively may later develop impaired healing, urinary extravasation, or delayed stricture because its segmental blood supply has been compromised. Understanding perfusion physiology therefore supports both preventive surgical technique and timely postoperative diagnosis.

Epidemiology / Disease Burden

Population-level estimates of isolated ureteric ischemia are limited because the condition is rarely coded as a distinct diagnosis. Most available evidence comes from case series involving postoperative ureteral strictures, urinary fistulae, transplant complications, aortic surgery, and critically ill patients with prolonged shock. The burden is likely underestimated because mild perfusion impairment may resolve without recognizable symptoms, while severe injury is often attributed to obstruction, infection, or technical complications.

Risk is particularly relevant in patients requiring prolonged vasopressor support or repeated operations. Pelvic oncologic procedures, colorectal surgery, radical hysterectomy, vascular reconstruction, and ureterolysis can disrupt periureteral adventitia and small arterial branches. Endovascular or open treatment of aortic and iliac disease may alter inflow to collateral vessels. In transplantation, an ischemic ureteric complication can result in urinary leakage or stricture and may threaten graft function. These outcomes are associated with prolonged hospitalization, recurrent interventions, sepsis, impaired quality of life, and increased healthcare utilization.

Pathophysiology

The ureter receives a longitudinally oriented, relatively delicate vascular supply. Proximal branches commonly arise from the renal artery and nearby aortic or gonadal vessels, whereas the middle and distal segments receive contributions from the common iliac, internal iliac, uterine, vesical, and other pelvic arteries. Small vessels form a longitudinal adventitial plexus with interconnections, but the network is not uniformly redundant. Excessive circumferential dissection, skeletonization, ligation of feeding vessels, or devascularizing mobilization can therefore create watershed segments.

Systemic shock reduces renal and pelvic perfusion pressure and may impair microcirculatory flow even when macroscopic arterial pressure has been restored. Sepsis contributes endothelial injury, capillary leakage, mitochondrial dysfunction, and heterogeneous tissue perfusion. Catecholamine-mediated vasoconstriction can preserve central pressure while limiting regional blood flow. Anemia and hypoxemia further reduce oxygen content, while acidosis and inflammation impair cellular energy production. The consequence may be epithelial injury, edema, loss of peristaltic coordination, smooth-muscle dysfunction, and progressive tissue necrosis.

Ischemic damage also interacts with urinary obstruction. A poorly perfused ureter may become edematous and aperistaltic, increasing upstream pressure and worsening local tissue compromise. Urine extravasation creates inflammation and infection risk. During healing, fibroblast activation and collagen deposition may produce a fixed stricture weeks or months after the original insult. This delayed pattern explains why an initially satisfactory postoperative course does not exclude clinically important vascular injury.

Risk Factors

Major systemic risk factors include prolonged hypotension, septic shock, hemorrhagic shock, cardiogenic shock, severe hypoxemia, low cardiac output, anemia, disseminated intravascular coagulation, and high-dose or prolonged vasopressor therapy. Diabetes, chronic kidney disease, peripheral arterial disease, smoking, atherosclerosis, and advanced age may reduce microvascular reserve. Hypothermia, coagulopathy, and severe metabolic acidosis can further impair tissue oxygenation and repair.

Local and procedural risks include extensive ureteral dissection, removal of periureteral tissue, devascularizing mobilization, prior radiation, pelvic fibrosis, recurrent malignancy, urinary diversion, transplantation, and complex aortic or iliac procedures. Thermal energy, inadvertent ligation, compression by clips or sutures, and prolonged ureteral instrumentation may produce combined ischemic and mechanical injury. The risk is also increased when multiple insults occur simultaneously, such as pelvic surgery followed by hypotension, infection, and urinary obstruction.

Clinical Features

Clinical manifestations are often nonspecific. Early findings may include reduced urine output, flank or abdominal pain, unexplained fever, ileus, rising inflammatory markers, or persistent sepsis despite apparently appropriate treatment. Some patients remain asymptomatic while a leak develops into a pelvic collection. Others present later with hydronephrosis, recurrent urinary tract infection, flank discomfort, renal dysfunction, or progressive decline in differential renal function.

After urinary reconstruction or transplantation, urinary leakage, drain fluid with a high creatinine concentration, prolonged drainage, or unexplained fluid accumulation should raise concern for anastomotic or ureteric compromise. Delayed ureteral stricture may present weeks to months after surgery. In critically ill patients, oliguria is not specific because it may reflect renal parenchymal injury, low cardiac output, obstruction, or medication effects. A change in urine output must therefore be interpreted alongside imaging, hemodynamic history, operative details, and renal function trends.

Diagnosis

Diagnosis begins with a structured review of hemodynamic exposure, vasopressor dose, operative dissection, urinary devices, fluid balance, and the timing of symptoms. Serial measurements of serum creatinine, urine output, lactate, hemoglobin, inflammatory markers, and drain-fluid creatinine may support assessment but cannot independently establish ureteric ischemia. Urinalysis may show hematuria or pyuria, although findings are frequently absent or nonspecific.

Ultrasonography is useful for detecting hydronephrosis, fluid collections, and changes in renal size, but it does not directly assess ureteral microperfusion. Contrast-enhanced computed tomography can identify extravasation, obstruction, collections, delayed renal enhancement, and alternative causes of deterioration. CT urography may delineate the level of a leak or stricture when renal function permits contrast administration. Retrograde pyelography remains valuable for defining ureteral continuity and obstruction, particularly when intervention is likely. Nuclear medicine studies can quantify differential renal function and drainage in delayed presentations.

Direct assessment of ureteral perfusion remains challenging. Intraoperative fluorescence techniques using indocyanine green, Doppler assessment, laser speckle methods, and other tissue-oxygenation technologies may provide qualitative information about vascularity, but thresholds for predicting delayed ischemic failure are not yet standardized. These tools should complement, rather than replace, careful preservation of the adventitial vascular network and clinical judgment.

Treatment & Management

Initial management prioritizes restoration of systemic oxygen delivery. This includes rapid treatment of hemorrhage or sepsis, optimization of preload and cardiac output, correction of severe anemia and hypoxemia, and judicious vasopressor use consistent with critical care principles. The goal is not simply to normalize a blood-pressure number but to improve global and regional perfusion while avoiding excessive vasoconstriction. Urinary obstruction should be relieved promptly with ureteric stenting or percutaneous nephrostomy when appropriate.

Suspected urinary leakage requires drainage of collections, antimicrobial treatment when infection is present, and diversion of urine away from the injured segment. Stable, limited leaks may heal with stenting and drainage. Complete disruption, extensive necrosis, or established ischemic stricture usually requires delayed reconstruction after inflammation and sepsis have resolved. Options include ureteroneocystostomy, psoas hitch, Boari flap, ureteroureterostomy, transureteroureterostomy, or more complex substitution procedures according to the location and length of the defect.

During surgery, preservation of periureteral tissue is fundamental. The ureter should be handled gently, with minimal stripping, limited use of cautery, avoidance of excessive tension, and protection from direct compression. A visibly viable segment may still have marginal perfusion; therefore, reconstruction should use well-vascularized tissue and tension-free anastomosis. Stenting and postoperative imaging are individualized according to the procedure, clinical risk, and evidence of obstruction or leakage.

Recent Advances / Emerging Therapies

Recent progress focuses on real-time assessment of tissue viability and improved prediction of delayed complications. Near-infrared fluorescence with indocyanine green is increasingly explored in reconstructive and transplant surgery to identify perfusion differences that are not apparent under white light. Quantitative fluorescence analysis, hyperspectral imaging, and microvascular Doppler methods may eventually provide reproducible thresholds for deciding whether a ureteral segment is suitable for anastomosis.

Research is also examining biomarkers of ischemia, computational models of ureteral blood flow, organ-preservation techniques, and regenerative approaches for strictures. Tissue-engineered grafts and cell-based therapies remain investigational and are not established replacements for sound surgical technique. Enhanced recovery pathways, standardized postoperative monitoring, and integrated electronic alerts for oliguria, drain abnormalities, and delayed hydronephrosis may improve recognition. Future studies should define clinically meaningful perfusion endpoints and evaluate outcomes across shock states, surgical specialties, and transplant populations.

Guideline Recommendations

Current urological and critical care guidance supports prompt correction of shock, source control of infection, decompression of obstructed systems, and early specialist involvement when urinary tract injury is suspected. Although major guidelines do not generally provide a standalone algorithm for ureteric ischemia, their principles consistently emphasize preservation of ureteral blood supply, avoidance of unnecessary dissection, drainage of urinomas, and repair by experienced reconstructive teams. Imaging should be selected according to renal function, stability, suspected complication, and the likelihood that an intervention will be required.

In high-risk operations, teams should document ureteral location, vascular preservation, intraoperative concerns, and postoperative surveillance plans. Persistent sepsis, unexplained fluid collections, new hydronephrosis, declining renal function, or delayed urinary leakage warrants prompt evaluation rather than prolonged observation. Management decisions should be individualized through collaboration among urologists, intensivists, radiologists, surgeons, nephrologists, and transplant specialists.

Conclusion

Prolonged hemodynamic instability can compromise ureteric perfusion through systemic hypoperfusion, vasoconstriction, microvascular dysfunction, anemia, hypoxemia, and disruption of segmental arterial supply. The resulting injury may be subtle initially and may later manifest as urinary leakage, necrosis, infection, obstruction, or stricture. Prevention depends on early hemodynamic resuscitation, preservation of periureteral tissue, avoidance of excessive dissection, and careful management of obstruction and infection. Diagnosis requires integration of clinical history, laboratory trends, cross-sectional imaging, contrast studies, and selective functional assessment. Fluorescence and other perfusion technologies are promising but require validation. Heightened clinical awareness and coordinated multidisciplinary care offer the best opportunity to preserve urinary tract function and reduce delayed morbidity.